- Home
- RGC
as 12-17-2024 4:00pm EST
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Upcoming Earnings Alert:
Get ready for potential market movements as Regencell Bioscience Holdings Limited RGC prepares to release earnings report on 20 Dec 2024.
| Founded: | 2014 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 105.3M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 51.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.03 - $32.44 | Next Earning Date: | 12-20-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Regencell Bioscience Holdings Limited News
RGC Breaking Stock News: Dive into RGC Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans
Simply Wall St.
5 months ago
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider, CEO Yat-Gai Au must be pleased with the recent 321% gain
PR Newswire
a year ago
NuZee, Inc. Announces Receipt of NASDAQ Notification
Business Wire
a year ago
Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets
GlobeNewswire
a year ago
Atlanticus Prices $50 Million Offering of Senior Notes
Thomson Reuters StreetEvents
a year ago
Q4 2023 First Merchants Corp Earnings Call
Zacks
a year ago
First Merchants (FRME) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
GlobeNewswire
a year ago
Jeffs’ Brands Announces Pricing of $7.275 Million Private Placement
Compare RGC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RGC Regencell Bioscience Holdings Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.